Conservation of behavioural topography to dopamine D1-like receptor agonists in mutant mice lacking the D(1A) receptor implicates a D1-like receptor not coupled to adenylyl cyclase

Neuroscience

Volumn 93, Issue 4, 1999, Pages 1483-1489

  Clifford, J J ^a   Tighe, O ^a   Croke, D T ^a   Kinsella, A ^b   Sibley, D R ^c   Drago, J ^d   Waddington, J L ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Adenylyl cyclase; Behaviour; D(1A) knockout; D1 like dopamine receptors; mutant mice

Indexed keywords

1 AMINOMETHYL 5,6 DIHYDROXY 3 PHENYLISOCHROMAN; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ADENYLATE CYCLASE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 1A RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; N (3 HYDROXYPHENETHYL) N (PHENETHYL)PROPYLAMINE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; ETHOLOGY; FEMALE; KNOCKOUT MOUSE; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSGENIC MOUSE;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ADENYLATE CYCLASE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; BRAIN CHEMISTRY; CHROMANS; DOPAMINE AGONISTS; FEMALE; GROOMING; LOCOMOTION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENETHYLAMINES; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2;

EID: 0032768254     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00297-3     Document Type: Article

References (40)

1. Arnt J., Hyttel J., Sanchez C. Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro. Eur. J. Pharmac. 213:1992;259-267.
2. 3 dopamine receptor antagonists using an ethologically based approach. Psychopharmacology. 136:1998;284-290.
3. 1A dopamine receptor: paradoxical elevation of grooming syntax. Neuropharmacology. 37:1998;1595-1602.
4. Cromwell H.C., Berridge K.C. Implementation of action sequences by a neostriatal site: a lesion mapping study of grooming syntax. J. Neurosci. 16:1996;3444-3458.
5. 1A-deficient mice. Eur. J. Neurosci. 10:1998;2426-2432.
6. Daly S.A., Waddington J.L. Behavioural evidence for "D-1-like" dopamine receptor subtypes in rat brain using the new isochroman agonist A 68930 and isoquinoline antagonist BW 737C. Psychopharmacology. 113:1993;45-50.
7. 1D receptor. J. biol. Chem. 270:1995;4005-4012.
8. 1 receptor. Eur. J. Pharmac. 199:1991;209-219.
9. 1-like" dopamine receptors not linked to adenylyl cyclase. Br. J. Pharmac. 116:1995;2120-2126.
10. 2-like" agonist RU 24213. Psychopharmacology. 124:1996;40-49.
11. 1-like" dopamine receptor agonists. Pharmac. Biochem. Behav. 58:1997;551-558.
12. 1A dopamine receptors. Proc. natn. Acad. Sci. U.S.A. 91:1994;12564-12568.
13. Euvrard C., Ferland L., DiPaulo T., Beaulieu M., Labrie F., Oberlander C., Raynaud J.P., Boissier J.R. Activity of two new potent dopaminergic agonists at the striatal and antierior pituitary levels. Neuropharmacology. 19:1980;379-386.
14. 1A knockout mice. Molec. Pharmac. 51:1997;6-11.
15. Iversen L.L. Dopamine receptors in the brain. Science. 188:1975;1084-1089.
16. Jaber M., Robinson S.W., Missale C., Caron M.G. Dopamine receptors and brain function. Neuropharmacology. 35:1996;1503-1519.
17. Jackson D.M., Westlind-Danielsson A. Dopamine receptors: molecular biology, biochemistry and behavioural aspects. Pharmac. Ther. 64:1994;291-370.
18. Jasin M., Moynahan M.-E., Richardson C. Targeted transgenesis. Proc. natn. Acad. Sci. U.S.A. 93:1996;8804-8808.
19. Johansen P.A., Hu X.-T., White F.J. Relationship between D-1 dopamine receptors, adenylate cyclase, and the electrophysiological responses of rat nucleus accumbens neurons. J. neural Transm. 86:1991;97-113.
20. Kebabian J.W., Petzgold G.L., Greengard P. Dopamine-sensitive adenylate cyclase in the caudate nucleus of rat brain and its similarity to the dopamine receptor. Proc. natn. Acad. Sci. U.S.A. 69:1972;2145-2149.
21. Kebabian J.W., Calne D.B. Multiple receptors for dopamine. Nature. 277:1979;93-96.
22. 2+ mobilisation in Xenopus oocytes. Proc. natn. Acad. Sci. U.S.A. 87:1990;2196-2200.
23. 1 receptor deficient mice. NeuroReport. 6:1995;2314-2316.
24. 1 antagonist SCH 23390. Psychopharmacology. 82:1984;409-410.
25. 2 interaction. Eur. J. Pharmac. 160:1989;377-384.
26. Neisewander J.L., Ong A., McGonigle P. Anatomical localisation of SK & F 38393-induced behaviours in rats using the irreversible monoamine receptor antagonist EEDQ. Synapse. 19:1995;134-143.
27. Seber G. A. F. Linear regression analysis. Wiley, Chichester.
28. Sibley D.R., Monsma F.J. Molecular biology of dopamine receptors. Trends pharmac. Sci. 13:1992;61-69.
29. 1A dopamine receptors. Neuroscience. 86:1998;135-146.
30. 1c dopamine receptors from Xenopus laevis. Proc. natn. Acad. Sci. U.S.A. 91:1994;10536-10540.
31. Undie A.S., Friedman E. Stimulation of a dopamine D-1 receptor enhances inositol phosphate formation in rat brain. J. Pharmac. exp. Ther. 253:1990;987-992.
32. 1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain. J. Neurochem. 62:1994;2045-2048.
33. 1 dopamine receptor agonist SKF 38393 in the rat. Psychopharmacology. 109:1992;41-48.
34. 2 Dopamine Receptor Interactions: Neuroscience and Psychopharmacology (ed. Waddington J. L.), pp. 71-78. Academic, London.
35. 2-like dopamine receptor systems. In Dopamine Receptors and Transporters: Pharmacology, Structure and Function, (ed. Niznik H. B.), pp. 511-537. Marcel Dekker, New York.
36. Waddington J.L., Daly S.A., Downes R.P., Deveney A.M., McCauley P.G., O'Boyle K.M. Behavioural pharmacology of 'D-1-like' dopamine receptors: further subtyping, new pharmacological probes and interactions with 'D-2-like' receptors. Prog. Neuropsychopharmac. biol. Psychiat. 19:1995;811-831.
37. Wei L.-N. Transgenic animals as new approaches in pharmacological studies. A. Rev. Pharmac. Toxicol. 37:1997;119-141.
38. 2 Dopamine Receptor Interactions: Neuroscience and Psychopharmacology (ed. Waddington J. L.), pp. 79-114. Academic, London.
39. 1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioural responses. Cell. 79:1994;729-742.
40. 1 receptor mutant mice. Cell. 79:1994;945-955.